Perrigo Company plc Income (Loss) from Equity Method Investments
Perrigo Company plc (PRGO) reported Income (Loss) from Equity Method Investments of -$300.00 thousand for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-05
- Perrigo Company plc income (loss) from equity method investments for the quarter ending 2026-06-27 was -$300.00K.
- Perrigo Company plc income (loss) from equity method investments for the quarter ending 2026-03-28 was $100.00K.
- Perrigo Company plc income (loss) from equity method investments for the quarter ending 2025-12-31 was -$33.60M.
- Perrigo Company plc income (loss) from equity method investments for the quarter ending 2025-09-27 was -$200.00K.
- Perrigo Company plc income (loss) from equity method investments for fiscal 2024 was -$1.50M.
- Perrigo Company plc income (loss) from equity method investments for fiscal 2023 was -$1.90M.
- Perrigo Company plc income (loss) from equity method investments for fiscal 2022 was -$1.50M.
- Perrigo Company plc income (loss) from equity method investments for fiscal 2021 was -$1.10M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-27 | -$300.00K 10-Q · filed 2026-08-05 | -$200.00K 10-Q · filed 2026-08-05 | -$33.80M derived: sum of 3 quarters · filed 2026-08-05 | -$34.00M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-28 | $100.00K 10-Q · filed 2026-05-06 | -$33.50M derived: sum of 2 quarters · filed 2026-05-06 | -$33.70M derived: sum of 3 quarters · filed 2026-05-06 | -$34.10M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | -$33.60M 10-K · filed 2026-02-26 | -$33.80M derived: sum of 2 quarters · filed 2026-02-26 | -$34.20M derived: sum of 3 quarters · filed 2026-08-05 | -$34.30M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-09-27 | -$200.00K 10-Q · filed 2025-11-05 | -$600.00K derived: sum of 2 quarters · filed 2026-08-05 | -$700.00K 10-Q · filed 2025-11-05 | -$900.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-28 | -$400.00K 10-Q · filed 2026-08-05 | -$500.00K 10-Q · filed 2026-08-05 | -$700.00K derived: sum of 3 quarters · filed 2026-08-05 | -$800.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-29 | -$100.00K 10-Q · filed 2026-05-06 | -$300.00K derived: sum of 2 quarters · filed 2026-05-06 | -$400.00K derived: sum of 3 quarters · filed 2026-05-06 | -$900.00K derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$300.00K derived: sum of 2 quarters · filed 2025-11-05 | -$800.00K derived: sum of 3 quarters · filed 2025-11-05 | -$1.50M 10-K · filed 2025-02-28 | |||
| 2024-09-28 | -$100.00K 10-Q · filed 2025-11-05 | -$600.00K derived: sum of 2 quarters · filed 2025-11-05 | -$1.30M 10-Q · filed 2025-11-05 | -$1.60M derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-29 | -$500.00K 10-Q · filed 2025-08-06 | -$1.20M 10-Q · filed 2025-08-06 | -$1.50M derived: sum of 3 quarters · filed 2025-08-06 | -$1.80M derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-30 | -$600.00K 10-Q · filed 2025-05-07 | -$1.00M derived: sum of 2 quarters · filed 2025-05-07 | -$1.30M derived: sum of 3 quarters · filed 2025-05-07 | -$1.80M derived: sum of 4 quarters · filed 2025-05-07 | |||
| 2023-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$700.00K derived: sum of 2 quarters · filed 2025-02-28 | -$1.20M derived: sum of 3 quarters · filed 2025-02-28 | -$1.90M 10-K · filed 2025-02-28 | |||
| 2023-09-30 | -$300.00K 10-Q · filed 2024-11-06 | -$800.00K derived: sum of 2 quarters · filed 2024-11-06 | -$1.50M 10-Q · filed 2024-11-06 | -$1.40M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-07-01 | -$500.00K 10-Q · filed 2024-08-02 | -$1.20M 10-Q · filed 2024-08-02 | -$1.10M derived: sum of 3 quarters · filed 2025-02-28 | -$1.40M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-04-01 | -$700.00K 10-Q · filed 2024-05-07 | -$600.00K derived: sum of 2 quarters · filed 2025-02-28 | -$900.00K derived: sum of 3 quarters · filed 2025-02-28 | -$1.50M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$200.00K derived: sum of 2 quarters · filed 2025-02-28 | -$800.00K derived: sum of 3 quarters · filed 2025-02-28 | -$1.50M 10-K · filed 2025-02-28 | |||
| 2022-10-01 | -$300.00K 10-Q · filed 2023-11-07 | -$900.00K derived: sum of 2 quarters · filed 2023-11-07 | -$1.60M 10-Q · filed 2023-11-07 | ||||
| 2022-07-02 | -$600.00K 10-Q · filed 2023-08-08 | -$1.30M 10-Q · filed 2023-08-08 | |||||
| 2021-12-31 | -$1.10M 10-K · filed 2024-02-27 | ||||||
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $200.00K derived: sum of 3 quarters · filed 2018-03-01 | $300.00K 10-K · filed 2018-03-01 | |||
| 2017-09-30 | -$100.00K 10-Q · filed 2017-11-09 | $100.00K derived: sum of 2 quarters · filed 2017-11-09 | $200.00K 10-Q · filed 2017-11-09 | -$100.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-07-01 | $200.00K 10-Q · filed 2017-08-10 | $300.00K 10-Q · filed 2017-08-10 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $100.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-04-01 | $100.00K 10-Q · filed 2017-05-30 | -$200.00K derived: sum of 2 quarters · filed 2018-03-01 | -$100.00K derived: sum of 3 quarters · filed 2018-03-01 | -$1.70M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$200.00K derived: sum of 2 quarters · filed 2018-03-01 | -$1.80M derived: sum of 3 quarters · filed 2018-03-01 | -$4.10M 10-K · filed 2018-03-01 | |||
| 2016-10-01 | $100.00K 10-Q · filed 2017-11-09 | -$1.50M derived: sum of 2 quarters · filed 2017-11-09 | -$3.80M 10-Q · filed 2017-11-09 | $3.90M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-07-02 | -$1.60M 10-Q · filed 2017-08-10 | -$3.90M 10-Q · filed 2017-08-10 | $3.80M derived: sum of 3 quarters · filed 2018-03-01 | $1.40M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-04-02 | -$2.40M 10-Q · filed 2017-05-30 | $5.40M derived: sum of 2 quarters · filed 2018-03-01 | $3.00M derived: sum of 3 quarters · filed 2018-03-01 | -$2.00M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $7.80M derived: 10-K 6 month − 10-Q/A 3 month · filed 2018-03-01 | $5.40M 10-K · filed 2018-03-01 | -$7.10M 10-KT · filed 2016-02-25 | $400.00K derived: sum of 3 quarters · filed 2018-03-01 | $100.00K derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-09-26 | -$2.40M 10-Q/A · filed 2017-05-23 | -$4.10M 10-Q · filed 2016-11-10 | -$7.40M derived: sum of 2 quarters · filed 2017-05-23 | -$7.70M 10-Q/A · filed 2017-05-23 | -$4.70M derived: sum of 4 quarters · filed 2017-05-23 | ||
| 2015-06-27 | -$5.00M 10-Q/A · filed 2017-05-22 | $3.50M 10-K · filed 2015-08-13 | -$5.30M 10-Q/A · filed 2017-05-22 | -$3.60M 10-Q · filed 2016-08-10 | -$2.30M derived: sum of 3 quarters · filed 2017-05-22 | $11.60M 10-K · filed 2018-03-01 | -$9.90M 10-K · filed 2015-08-13 |
| 2015-03-28 | -$300.00K 10-Q/A · filed 2017-05-22 | $2.70M derived: sum of 2 quarters · filed 2017-05-22 | -$400.00K derived: sum of 3 quarters · filed 2017-05-22 | -$4.00M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-12-27 | $3.00M 10-K · filed 2015-08-13 | $1.30M 10-Q · filed 2015-02-05 | -$3.70M derived: sum of 3 quarters · filed 2017-05-22 | -$7.50M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-09-27 | -$3.10M 10-Q · filed 2015-11-02 | $0.00 10-Q · filed 2014-11-06 | -$6.70M derived: sum of 2 quarters · filed 2017-05-22 | -$10.50M derived: sum of 3 quarters · filed 2017-05-22 | |||
| 2014-06-28 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | -$7.40M derived: sum of 2 quarters · filed 2017-05-22 | -$8.70M 10-K · filed 2017-05-22 | ||||
| 2014-03-29 | -$3.80M 10-Q · filed 2015-04-29 | -$5.10M 10-Q · filed 2015-04-29 | |||||
| 2013-09-28 | $0.00 8-K · filed 2014-11-20 | ||||||
| 2012-06-30 | $0.00 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |